Certara (NASDAQ:CERT) Trading Down 5.7% - Here's Why

Key Points

• Certara shares fell 5.7% on Friday, trading as low as $6.87 and well below the prior close of $7.28, with volume also coming in far below average.
• Recent analyst activity has been mixed but generally cautious, with multiple firms cutting price targets and the consensus rating sitting at Hold with an average target of $8.85.
• The company’s latest earnings showed EPS of $0.09, missing estimates, while revenue was slightly above expectations and up just 0.8% year over year.

Shares of Certara, Inc. (NASDAQ:CERT - Get Free Report) dropped 5.7% during trading on Friday . The stock traded as low as $6.87 and last traded at $6.8660. 793,302 shares traded hands during mid-day trading, a decline of 78% from the average session volume of 3,683,374 shares. The stock had previously closed at $7.28.

Analysts Set New Price Targets

Several research firms have recently weighed in on CERT. Weiss Ratings reiterated a "sell (e+)" rating on shares of Certara in a research report on Friday, May 29th. Craig Hallum cut their price target on Certara from $10.00 to $8.00 and set a "hold" rating on the stock in a report on Tuesday, May 12th. Barclays reduced their price objective on shares of Certara from $8.00 to $6.50 and set an "equal weight" rating for the company in a research report on Tuesday, May 12th. KeyCorp dropped their target price on shares of Certara from $10.00 to $8.00 and set an "overweight" rating on the stock in a research report on Monday, April 13th. Finally, Morgan Stanley reduced their price target on shares of Certara from $11.00 to $10.00 and set an "equal weight" rating for the company in a report on Tuesday, May 12th. One analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Certara has an average rating of "Hold" and an average price target of $8.85.

Certara Trading Down 4.7%

The business has a fifty day moving average of $5.76 and a 200-day moving average of $6.71. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.88 and a current ratio of 1.88. The company has a market capitalization of $1.08 billion, a P/E ratio of -69.19 and a beta of 1.46.

Certara (NASDAQ:CERT - Get Free Report) last released its quarterly earnings data on Monday, May 11th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.11 by ($0.02). The business had revenue of $106.92 million for the quarter, compared to analyst estimates of $106.13 million. Certara had a positive return on equity of 3.52% and a negative net margin of 3.60%.The business's quarterly revenue was up .8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.14 EPS. Certara has set its FY 2026 guidance at 0.350-0.410 EPS. Analysts anticipate that Certara, Inc. will post 0.24 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Certara

A number of hedge funds have recently added to or reduced their stakes in the stock. Osaic Holdings Inc. raised its stake in shares of Certara by 50.7% in the second quarter. Osaic Holdings Inc. now owns 3,491 shares of the company's stock worth $41,000 after purchasing an additional 1,175 shares during the last quarter. Corient Private Wealth LLC grew its holdings in Certara by 11.7% during the second quarter. Corient Private Wealth LLC now owns 12,362 shares of the company's stock worth $144,000 after buying an additional 1,295 shares in the last quarter. Central Pacific Bank Trust Division raised its position in Certara by 8.7% in the 2nd quarter. Central Pacific Bank Trust Division now owns 19,460 shares of the company's stock valued at $127,000 after buying an additional 1,558 shares during the last quarter. Treasurer of the State of North Carolina lifted its stake in Certara by 2.9% during the 2nd quarter. Treasurer of the State of North Carolina now owns 56,628 shares of the company's stock valued at $663,000 after acquiring an additional 1,597 shares in the last quarter. Finally, Nicolet Advisory Services LLC lifted its stake in Certara by 7.4% during the 3rd quarter. Nicolet Advisory Services LLC now owns 30,608 shares of the company's stock valued at $396,000 after acquiring an additional 2,100 shares in the last quarter. Institutional investors and hedge funds own 73.96% of the company's stock.

Certara Company Profile

Certara is a biosimulation software and services company that partners with pharmaceutical, biotechnology and medical device developers to accelerate drug discovery, development and regulatory approval. The company's platform integrates quantitative pharmacology, real-world evidence, artificial intelligence and machine learning to model and simulate drug behavior across a range of therapeutic areas and patient populations. By applying these mechanistic and data-driven approaches, Certara helps its clients predict clinical outcomes, optimize dosing strategies and streamline decision-making throughout the product lifecycle.

The company's offerings are divided into software tools and consulting services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.